Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,936.00
Bid: 2,954.00
Ask: 2,956.00
Change: -46.00 (-1.54%)
Spread: 2.00 (0.068%)
Open: 2,984.00
High: 2,984.00
Low: 2,936.00
Prev. Close: 2,982.00
BNZL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

20 Apr 2022 07:00

RNS Number : 6454I
Bunzl PLC
20 April 2022
 

20 April 2022

 

BUNZL Q1 TRADING STATEMENT

 

Bunzl plc, the specialist international distribution and services Group, today announces its trading statement for the period since 31 December 2021.

 

Bunzl's diversified and resilient business model has delivered strong growth, with Group revenue in the first quarter up 13.2% at actual exchange rates and 12.5% at constant exchange rates. At constant exchange rates, underlying revenue growth which is organic growth adjusted for trading days was 11.0%, mainly driven by inflation, with fewer trading days than the comparable period negatively impacting revenue by 1.7%. Acquisitions contributed further growth of 3.2% at constant exchange rates.

 

Underlying revenue growth of 11.0% was driven by continued momentum in the base business which contributed 17% growth, which significantly benefited from inflation. This was partially offset by the expected decline in sales from the top 8 Covid-19 related products which impacted underlying revenue by 6%, driven by product deflation compared to the prior year period. Overall, inflation remained particularly supportive to our businesses in North America, while the UK & Ireland and Continental Europe delivered very strong growth compared to the prior year due to inflation and recovery of the base business.

 

The Group's guidance remains unchanged. At constant exchange rates the Group expects moderate revenue growth in 2022, driven by the impact of acquisitions completed in the last 12 months and supported by a slight increase in organic revenue. Continued recovery of the base business is expected to be partially offset by the further normalisation of sales of Covid-19 related products. We also expect Group operating margin in 2022 to be slightly higher than historical levels.

 

Commenting on today's results, Frank van Zanten, Chief Executive Officer of Bunzl, said:

 

"Our entrepreneurial teams have continued to deliver good growth through a combination of passing on substantial inflation and volume growth, supported by recovering markets and with our performance over the last two years further strengthening our competitive position. Our diversified portfolio remains a key determinant of the strength and resilience of our performance. We continue to focus on delivering our long-term strategic objectives that will drive further compounding growth. Our acquisition pipeline is active and supported by our strong balance sheet."

 

Enquiries:

 

Bunzl plc

Frank van Zanten, Chief Executive Officer

Richard Howes, Chief Financial Officer

Sunita Entwisle, Head of Investor Relations

Tel: +44 (0)20 7725 5000

Tulchan

Martin Robinson

Olivia Peters

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBUGDSBXBDGDC
Date   Source Headline
9th Oct 20175:30 pmRNSDirector/PDMR Shareholding
9th Oct 20175:25 pmRNSDirector/PDMR Shareholding
9th Oct 20175:21 pmRNSDirector/PDMR Shareholding
6th Oct 20174:00 pmRNSDirector/PDMR Shareholding
6th Oct 201712:20 pmRNSDirector/PDMR Shareholding
5th Oct 20173:55 pmRNSHolding(s) in Company
2nd Oct 201711:30 amRNSTotal Voting Rights
29th Sep 20174:15 pmRNSDirector/PDMR Shareholding
27th Sep 20177:00 amRNSCapital Markets Event
22nd Sep 20173:00 pmRNSDirector/PDMR Shareholding
14th Sep 20179:10 amRNSHolding(s) in Company
6th Sep 20179:07 amRNSHolding(s) in Company
1st Sep 20174:40 pmRNSDirector/PDMR Shareholding
1st Sep 201711:10 amRNSTotal Voting Rights
29th Aug 201712:15 pmRNSDividend Declaration
29th Aug 20177:00 amRNSHalf-year Report
29th Aug 20177:00 amRNSAcquisition
15th Aug 201710:13 amRNSAdditional Listing
9th Aug 20172:56 pmRNSHolding(s) in Company
7th Aug 201712:09 pmRNSHolding(s) in Company
2nd Aug 20172:56 pmRNSHolding(s) in Company
1st Aug 201710:34 amRNSTotal Voting Rights
20th Jul 20177:00 amRNSAcquisition
14th Jul 20171:12 pmRNSDirector/PDMR Shareholding
5th Jul 20173:30 pmRNSDirector/PDMR Shareholding
3rd Jul 20172:01 pmRNSTotal Voting Rights
3rd Jul 20179:50 amRNSHolding(s) in Company
3rd Jul 20179:00 amRNSDirector Declaration
28th Jun 20177:00 amRNSTrading Statement
6th Jun 20171:13 pmRNSDirector/PDMR Shareholding
2nd Jun 20173:51 pmRNSHolding(s) in Company
1st Jun 201710:26 amRNSTotal Voting Rights
24th May 20177:00 amRNSAcquisition
3rd May 20174:47 pmRNSDirector/PDMR Shareholding
3rd May 20174:42 pmRNSBlock listing Interim Review
2nd May 20174:21 pmRNSDirector/PDMR Shareholding
2nd May 20174:19 pmRNSDirector/PDMR Shareholding
2nd May 20173:35 pmRNSTotal Voting Rights
27th Apr 20175:38 pmRNSDirector/PDMR Shareholding
26th Apr 20179:54 amRNSAdditional Listing
19th Apr 20172:20 pmRNSResult of AGM
19th Apr 20177:00 amRNSTrading Statement
13th Apr 20171:56 pmRNSDirector/PDMR Shareholding
13th Apr 201710:21 amRNSAdditional Listing
11th Apr 20175:12 pmRNSDirector/PDMR Shareholding
7th Apr 20175:12 pmRNSDirector/PDMR Shareholding
6th Apr 20174:16 pmRNSDirector/PDMR Shareholding
4th Apr 20174:34 pmRNSDirector/PDMR Shareholding
4th Apr 20177:00 amRNSAcquisition
3rd Apr 20179:43 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.